Related Experiment Videos
Lithium: clinical considerations in internal medicine
Marlene P Freeman1, Scott A Freeman
1Women's Mental Health Program, Department of Psychiatry, University of Arizona College of Medicine, Tucson, AZ 85724-5002, USA. marlenef@email.arizona.edu
The American Journal of Medicine
|June 6, 2006
Summary
Lithium is an effective and affordable treatment for bipolar disorder, addressing mania, depression, and prevention. It uniquely reduces suicide rates in patients, remaining a vital intervention for mood disorders.
Area of Science:
- Psychiatry and Behavioral Sciences
- Pharmacology
Background:
- Bipolar disorders affect up to 5% of the population.
- While pharmacological treatments have advanced, lithium remains a key therapeutic option.
Purpose of the Study:
- To review the efficacy and applications of lithium in treating bipolar disorder.
- To discuss special population use, side effects, toxicity, and drug interactions.
- To provide laboratory monitoring guidelines for lithium therapy.
Main Methods:
- Literature review of lithium's role in mood disorder treatment.
- Analysis of efficacy in acute mania, bipolar depression, and prophylaxis.
- Examination of lithium's effect on suicide rates and its use as an augmentation agent.
Main Results:
- Lithium is effective for acute mania, bipolar depression, and prophylaxis.
- It is the only mood stabilizer proven to reduce suicide rates.
- The review covers special populations, side effects, toxicity, and drug interactions.
Conclusions:
- Lithium is an inexpensive, efficacious, and essential treatment for bipolar disorder.
- It plays a critical role in managing mood disorders and reducing suicide risk.
- Comprehensive monitoring and understanding of its use are crucial for patient care.
Related Concept Videos
01:24Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...